Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2012
06/14/2012US20120148599 Methods and compositions for neural disease immunotherapy
06/14/2012US20120148597 Human monoclonal antibodies to ctla-4
06/14/2012US20120148594 Mimotopes of hiv and uses thereof
06/14/2012US20120148592 Neutralizing anti-ccl20 antibodies
06/14/2012US20120148590 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
06/14/2012US20120148585 Fusion molecules and methods for treatment of immune diseases
06/14/2012US20120148582 Engineered anti-il-23r antibodies
06/14/2012US20120148580 Methods for identification of sites for igg conjugation
06/14/2012US20120148578 Methods and compositions for inhibiting cd32b expressing cells
06/14/2012US20120148572 Novel antibodies
06/14/2012US20120148571 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and uses thereof
06/14/2012US20120148567 Particulate hyaluronic acid formulations for cellular delivery of bioactive agents
06/14/2012US20120148564 Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activity
06/14/2012US20120148561 Use of runx3 and mir-532-5p as cancer markers and therapeutic targets
06/14/2012US20120148559 Compositions and method for deimmunization of proteins
06/14/2012US20120148555 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/14/2012US20120148553 Methods of generating natural killer cells
06/14/2012US20120148552 Method and compositions for enhanced anti-tumor effector functioning of t cells
06/14/2012US20120148551 Marrow stem cell and pancreatic beta cell fusion cell useful for the treatment of diabetes
06/14/2012US20120148550 Methods, systems, and compositions for neuronal differentiation of multipotent stromal cells
06/14/2012US20120148549 Method to isolate, identify, and use embryonic stem cells directed to forebrain interneuron fate
06/14/2012US20120148548 Joint Repair Using Mesenchymal Stem Cells
06/14/2012US20120148546 Pericyte progenitor cells and methods of generating and using same
06/14/2012US20120148545 Cardiac muscle repair or regeneration using bone marrow-derived stem cells
06/14/2012US20120148544 Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro
06/14/2012US20120148543 Synthetic graft
06/14/2012US20120148540 Proliferated cell lines and uses thereof
06/14/2012US20120148539 Methods and Compositions for Tissue Engineering
06/14/2012US20120148538 Composition for hard tissue formation and, dentin or pulp regeneration containing ameloblast, apical bud cell or its culture fluid as an active ingredient
06/14/2012US20120148537 Methods to enhance cell migration and engraftment
06/14/2012US20120148536 Methods and storage and retrieval of functional mature retinal cells
06/14/2012US20120148530 Method for the treatment or prevention of virus infection using polybiguanide-based compounds
06/14/2012US20120148529 Use of Inclusion Bodies as Therapeutic Agents
06/14/2012US20120148527 TNF Superfamily Fusion Proteins
06/14/2012US20120148500 Use of a Fluorinated Polymer as a Contrast Agent in Solid State 19F Magnetic Resonance Imaging (MRI), Scaffold Comprising Said Polymer and Use Thereof
06/14/2012US20120148495 Methods for treating nicotinic acetylcholine receptor associated diseases
06/14/2012US20120148490 Anti-ngf compositions and use thereof
06/14/2012US20120145626 Device for renal cell expansion
06/14/2012US20120145544 Novel ubiquitin ligase and use thereof
06/14/2012CA2820681A1 Use of chimeric antigen receptor-modified t cells to treat cancer
06/14/2012CA2820642A1 Galectin-9-secreting cell, and production method and use of the same
06/14/2012CA2820419A1 Agents and methods for inhibiting human pluripotent stem cell growth
06/14/2012CA2820395A1 Sub-totipotent stem cell product and epigenetic modification label thereof
06/14/2012CA2820134A1 Human monoclonal antibody
06/14/2012CA2819675A1 Methods of small molecule directed regeneration from pluripotent stem cells
06/14/2012CA2817874A1 Feed mixing device and its use
06/14/2012CA2815933A1 Efficient and effective supplement screening for the development of chemically defined media in cell culture
06/13/2012EP2463653A1 Technique for classifying cells, image processing program and image processing device using the technique, and method for producing cell mass
06/13/2012EP2463367A1 Novel ubiquitin ligase and use thereof
06/13/2012EP2463361A1 Methods to derive stem cells and to induce the proliferation of a single isolated blastomere
06/13/2012EP2463360A1 Methods for cell culture using a synthetic defined collagen mimetic surface
06/13/2012EP2463301A1 Synthetic, defined fibronectin mimetic peptides and surfaces modified with the same
06/13/2012EP2462936A1 SiRNA mediated post-transriptional gene-silencing of genes involved in alopecia
06/13/2012EP2462230A2 Methods and compositions for targeted gene modification
06/13/2012EP2462225A1 Method of efficiently establishing induced pluripotent stem cells
06/13/2012EP2462222A1 Improved plants, microbes, and organisms
06/13/2012EP2462163A1 Beta cell marker antibody
06/13/2012EP2461833A1 Vaccine composition comprising 5'-cap modified rna
06/13/2012EP2407479A9 Self-assembling peptide and peptide gel with high strength
06/13/2012EP2129774B1 Cells for heart treatment
06/13/2012EP2032690B1 Method for the in vitro preparation of living cells and/or cell accumulations from tissue
06/13/2012EP2019858B1 Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
06/13/2012EP1869166B1 In vitro production of a cell population using feeder cells
06/13/2012EP1702058B1 Methods and devices for microencapsulation of cells
06/13/2012EP1597382B1 Genetically modified non-human mammals and cells
06/13/2012EP1495053B1 Angiopoietin-2 and angiopoietin-1 specific binding agents
06/13/2012EP1494697B1 Monomeric and dimeric fluorescent protein variants and methods for making same
06/13/2012EP1490110B1 Anti-alpha v beta 6 antibodies
06/13/2012EP1478761B1 Degradation of hydrophobic ester pesticides and toxins
06/13/2012EP1442057B1 Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy
06/13/2012EP1414471B1 Therapeutic agents comprising pro-apoptotic proteins
06/13/2012EP1409646B1 Transgenic animals comprising a humanized immune system
06/13/2012EP1379535B1 Expression vectors able to elicit improved immune response and methods of using same
06/13/2012EP1297017B1 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
06/13/2012EP0904288B1 Vaccine comprising the pathogenic escherichia coli associated protein espa
06/13/2012EP0451216B2 Humanized immunoglobulins and their production and use
06/13/2012CN1950501B AMP deaminase originating in streptomyces and utilization thereof
06/13/2012CN1930301B Methods for identifying proteins with starch phosphorylating enzymatic activity
06/13/2012CN1835976B Aglycosyl anti- CD154 (CD 40 ligand) antibodies and uses thereof
06/13/2012CN1606567B Antimicrobial polypeptides from pseudoplectania nigrella
06/13/2012CN102498208A Gene capable of regulating number of primary panicle branches and use thereof
06/13/2012CN102498206A Production of proteins in glutamine-free cell culture media
06/13/2012CN102498205A Method for isolation of dermal stem cell
06/13/2012CN102492710A Beta-glucosidase Cel1b, expression gene and application thereof
06/13/2012CN102492704A Peanut AhFatA protein, coding gene and application thereof
06/13/2012CN102492700A DNA sequence for coding delta15 fatty acid desaturase (FAD) of Myrmecia incisa and application thereof
06/13/2012CN102492694A Brassica oleracea TT2 (transparent testa 2) gene and its application
06/13/2012CN102492688A Soybean pod borer 18srDNA gene and its application
06/13/2012CN102492658A PSer86 monoclonal antibody of Tip60, as well as preparation method and application of pSer86 monoclonal antibody
06/13/2012CN102492657A Drug screening cell model using NF-kappa B as target and building and applications thereof
06/13/2012CN102492656A High-flux anti-tumor drug screening cell model based on STAT3 and NF-kB two-signal channel serving as target, as well as building and application of high-flux anti-tumor drug screening cell model
06/13/2012CN102492655A Preparation and identification method of human leukemia cell cytoplast
06/13/2012CN102492654A Kit for separating human umbilical cord blood stem cells and its using method
06/13/2012CN102492653A Method for inducing and differentiating mature fat cell from adult rabbit into cardiomyocyte
06/13/2012CN102492652A Method for producing human stem cell by using egg
06/13/2012CN102492651A Method for differentiating human amniotic epithelial cell into insulin secreting cell by virtue of in-vitro induction
06/13/2012CN102492650A Construction method for Hexagrammos otakii cell line
06/13/2012CN102492649A Agaricus bisporus protoplast and preparation method thereof
06/13/2012CN102492648A Preparation method of porous chitosan scaffold
06/13/2012CN102492039A Fully humanized antihuman HER2 monoclonal antibody